Angelalign Technology announces results for the first half of 2025 and at the same time increases investments in the areas of law, Li

Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) has announced its interim results for the first half of 2025. The company achieved solid performance in the first six months of the year.

In the first half of 2025, Angel recorded an increase in sales of 33.1 % compared to the previous year to $ 161.4 million, with a gross profit of $ $ 100.6 million and an adjusted net profit of $ 19.5 million. The global volume of clear-aligner treatments rose by 47.7 % to around 225,800 cases compared to the previous year.

The growth in case deliveries as well as the efficient processes in the treatment planning centers and production facilities for transparent braces led to an improvement in sales, gross profit and the profit compared to the previous year. The profitability of the company in the reporting period also benefited from strict cost management in the expectation of an uncertain customs environment, including the delay in the hiring of certain employees in the areas of sales and marketing, clinical support and customer service as well as the delay in the operation of our treatment planning centers and production facilities outside the mainland Chinese mainland.

Angel strategically increases its long -term investments in several key areas to build a more sustainable international presence. The company plans to increase its investments in sales and marketing, clinical support and customer service, to set up and operate treatment planning centers and production facilities outside China, to continuously strengthen its legal capacities to protect intellectual property (“IP”) and to continue compliance with regulations and to further improve its data security infrastructure.

In markets outside of mainland china, the fall volume of Angel rose by 103.5 % to 117,200 cases compared to the previous year. The strong growth reflects both the low starting base in the previous year and initial success in new markets. Angel expanded its range with high -quality treatment planning, reliable deliveries and continuous further training programs with important opinion leaders (KOLS).

On the Chinese mainland market, Angel’s sales volume rose by 14 % to around 108,600 cases compared to the previous year. The company implemented a future -oriented growth strategy, prioritizing early orthodontic treatments and emerging markets as important driving forces for sustainable growth.

In the first half of 2025, Angel introduced innovative products and solutions that concentrated on early orthodontic treatment and complex cases and at the same time integrated intelligent initial consultations and tools for treatment monitoring in its solutions. The company carried out research work together with several universities in order to produce important clinical innovations.

The company’s IP strategy and compliance remain central priorities. In the course of its global expansion, Angel made considerable investments in strengthening its legal skills. The company plans to continue its tradition of product innovation and at the same time vigorously defend its rights to intellectual property.

In order to meet the growing market demand, Angel builds an intelligent production system from world -class in which user orientation, ecological sustainability and scalability are in the foreground. The company plans to build or expand production and treatment planning systems at important locations worldwide in order to ensure prompt and stable supply of its customers worldwide with products and services. For example, treatment planning centers in Brazil and Southeast Asia are currently offering treatment planning services for the United States.

The company has also invested considerable resources to improve data security infrastructure and operational processes to ensure compliance with data security and data protection regulations in all important markets. So far, this has been a significant investment and will continue to remain an ongoing task.

Fox Hu, CEO von Angel, said: “We are still confident about the long-term growth prospects of the global clear-aligner industry. The most important priorities include scaling aligners and treatment plans, improving our tradition of product innovation with adequate protection of intellectual property, increasing our investments in the Compliance and the promotion of sustainable growth in all regions. “

Information on Angelalign Technology Inc. Angelalign Technology Inc. was founded in 2003 and has already given 1.5 million people a radiant smile. The company offers digital, technology -based products and services in the field of transparent braces that meet the requirements of dentists and patients worldwide. The company’s innovative products and technical services have made it a leading provider in the orthodontic industry. In 2021, Angelalign Technology Inc. was noted on the Hong Kong Stock Exchange. In 2023, the company started its global expansion strategy, so that its products and services are now offered in over 50 countries and regions. Find out more at Angelaligner.com.

sue.kolb@angelaligner.com

link slot gacor

demo slot

link slot demo

link slot demo

By adminn